Clinical trial Recruiting at 1 site Observational Ages 45 to 75

Treatment for Thoracic Aortic Aneurysms and Valve Conditions

Official title: Clinical Study of Diagnosis and Treatment of Thoracic Aortic Aneurysms and Dilatation in Combination With Tricuspid and Bicuspid Aortic Valves.

Run by Tomsk National Research Medical Center of the Russian Academy of Sciences · NCT04372563 · Data updated 2026-11-12

This study is trying to see if surgery is the right choice for patients with slightly enlarged aortas and specific heart valve conditions, to help improve treatment guidelines for thoracic aortic aneurysms.

More Ascending Aortic Aneurysm trials

Quick facts

Study typeObservational
Ages45 Years to 75 Years
SexAll
Enrollment80 (estimated)
SponsorTomsk National Research Medical Center of the Russian Academy of Sciences
Academic / other
Locations2 sites (Tomsk and 1 other locations)
StatusRecruiting
StartedJanuary 24, 2020
Main results expectedJanuary 24, 2025
Study endsJanuary 24, 2026
Registry record updatedNovember 25, 2024
Trial IDNCT04372563 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 45 to 75 years with an ascending aorta measurement between 45 mm and 55 mm and tricuspid aortic valves.

Probably not a fit

Patients with multiple organ failure, oncological diseases, or those outside the age range of 45 to 75 years may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to clarify the indications for surgical correction in patients with borderline expansion of the ascending aorta, specifically focusing on those with tricuspid and bicuspid aortic valves. It involves observational assessments of patients with ascending aorta measurements between 45 mm and 55 mm to determine the appropriateness of surgical intervention. The study will evaluate the outcomes of aortic prosthetics in these patients to expand the criteria for surgical treatment. By analyzing these cases, the study seeks to provide clearer guidelines for managing thoracic aortic aneurysms.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical guidelines and outcomes for patients with borderline ascending aorta conditions.

How similar studies have gone: While this approach is focused on expanding surgical indications, similar studies have shown success in refining treatment criteria for aortic conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Extension of the ascending aorta less than 55 mm
2. Tricuspid Aortic Valves.
3. Extension of the ascending aorta more than 45 mm

Exclusion Criteria:

1. Age less 45 years
2. Age more 75 years
3. Multiple organ failure
4. oncological disease

Where it's running

  • Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
    Tomsk, Russia
    Recruiting
  • Tomsk National Research Medical Center of the Russian Academy of Sciences
    Tomsk, Russia
    Active not recruiting

Study contacts

  • Principal investigator: Evgeniya V Lelik, PhD — Tomsk National Research Medical Center of the Russian Academy of Sciences
  • Study coordinator: Boris N Kozlov, MD
  • Email: hospital@cardio-tomsk.ru
  • Phone: 3822558122

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.